Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients Riguel J. InaokaAchim A. JungbluthGisele W. B. Colleoni Original Article 26 May 2012 Pages: 2207 - 2214
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope Hiroya KobayashiTakumi KumaiEsteban Celis Original article 26 May 2012 Pages: 2215 - 2225
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer Raquibul HannanHuagang ZhangChandan Guha Original article 27 May 2012 Pages: 2227 - 2238
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma Miriam AlbChristopher SieDavid Schrama Original article Open access 07 June 2012 Pages: 2239 - 2249
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer Liangrong ShiQi ZhouChangping Wu Original article Open access 07 June 2012 Pages: 2251 - 2259
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma Mark R. AlbertiniJacquelyn A. HankPaul M. Sondel Original article 08 June 2012 Pages: 2261 - 2271
Mast cells impair the development of protective anti-tumor immunity Anna WasiukDyana K. DaltonRandolph J. Noelle Original article 10 June 2012 Pages: 2273 - 2282
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax) Richard HarropPeter TreasureWilliam H. Shingler Original article 13 June 2012 Pages: 2283 - 2294
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1 Pearline Zhaoying TeoPaul J. UtzJoseph A. Mollick Original article 13 June 2012 Pages: 2295 - 2309
Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay Yasuto AkiyamaMasaru KomiyamaKen Yamaguchi Original article 16 June 2012 Pages: 2311 - 2319
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells Amélie VézinaRima ChokorBorhane Annabi Original article 16 June 2012 Pages: 2321 - 2331
Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis Fenella J. RichSabine KuhnJoanna R. Kirman Original article 20 June 2012 Pages: 2333 - 2342
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo Connie JackamanDavid MajewskiDelia J. Nelson Original article 20 June 2012 Pages: 2343 - 2356
Effective modulation of CD4+CD25+high regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2 Guangxian LiuWuwei YangBing Liu Original Article Open access 22 June 2012 Pages: 2357 - 2366
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study Carmen D. SchweighoferArmin TuchschererMichael Hallek Short Communication 23 October 2012 Pages: 2367 - 2373
The new aspects of immunotherapy in prostate cancer Mostafa GhaneiMajid ShohratiAmin Saburi Letter to the editors 27 June 2012 Pages: 2375 - 2376
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer Matteo BelloneNicolò Rigamonti Letter to the editors 28 June 2012 Pages: 2377 - 2378
